These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 27114893)
1. Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections. Stanfield B; Kousoulas KG Curr Clin Microbiol Rep; 2015 Sep; 2(3):125-136. PubMed ID: 27114893 [TBL] [Abstract][Full Text] [Related]
2. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501 [TBL] [Abstract][Full Text] [Related]
3. [Herpes simplex virus vaccine studies: from past to present]. Us D Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702 [TBL] [Abstract][Full Text] [Related]
4. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407 [TBL] [Abstract][Full Text] [Related]
5. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes. Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
7. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846 [TBL] [Abstract][Full Text] [Related]
13. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. Kennedy PG; Rovnak J; Badani H; Cohrs RJ J Gen Virol; 2015 Jul; 96(Pt 7):1581-602. PubMed ID: 25794504 [TBL] [Abstract][Full Text] [Related]
14. Developments in Vaccination for Herpes Simplex Virus. Krishnan R; Stuart PM Front Microbiol; 2021; 12():798927. PubMed ID: 34950127 [TBL] [Abstract][Full Text] [Related]
15. Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses. Stanfield BA; Rider PJF; Caskey J; Del Piero F; Kousoulas KG Vaccine; 2018 May; 36(20):2842-2849. PubMed ID: 29655629 [TBL] [Abstract][Full Text] [Related]
16. Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials. Bernstein DI; Cardin RD; Pullum DA; Bravo FJ; Kousoulas KG; Dixon DA PLoS One; 2019; 14(3):e0213401. PubMed ID: 30917165 [TBL] [Abstract][Full Text] [Related]
17. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Da Costa XJ; Morrison LA; Knipe DM Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897 [TBL] [Abstract][Full Text] [Related]
18. Control of STDs--the role of prophylactic vaccines against herpes simplex virus. Stanberry LR Sex Transm Infect; 1998 Dec; 74(6):391-4. PubMed ID: 10195045 [TBL] [Abstract][Full Text] [Related]
19. An M2 Rather than a T Lee DH; Ghiasi H J Virol; 2018 May; 92(10):. PubMed ID: 29491152 [TBL] [Abstract][Full Text] [Related]